Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.

Medical Oncology - Tập 38 - Trang 1-2 - 2021
Cem Onal1, Ezgi Oymak2, Ozan Cem Guler1
1Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Centre, Baskent University Faculty of Medicine, Adana, Turkey
2Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay, Turkey

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Medical Oncology

Tập 38

1-2

Thông tin tác giả